NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…
Pfizer and Moderna’s updated vaccines will be available for people six months and older, while Novavax’s vaccine will be aimed…
Minneapolis (www.aktiencheck.de) - Rating-Update:
Edward Tenthoff, Analyst von Piper Sandler, bewertet die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Apple, Nvidia, Intel, Coinbase and Moderna fall premarket…
Moderna plunges on downgrade amid vaccine headwinds…
Toronto (www.aktiencheck.de) - Rating-Update:
Die Analysten vom Investmenthaus RBC Capital Markets stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…
Zürich (www.aktiencheck.de) - Rating-Update:
Die Analysten der UBS stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
Wall Street is reacting to the July jobs report. Economists had expected the economy to have added 175,000 jobs and…
…
MRNA earnings call for the period ending June 30, 2024.…
MRNA earnings call for the period ending June 30, 2024.…
Stocks that traded heavily or had substantial price changes on Thursday: Meta Platforms, Shake Shack rise; Moderna, Goodyear fall…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plummeted almost 20% after the vaccine maker slashed its full-year sales forecast for respiratory vaccines…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plummeted almost 20% after the vaccine maker slashed its full-year sales forecast for respiratory vaccines…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Andreas Deutsch vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Die jüngsten Quartalszahlen von Moderna haben zu einem signifikanten Kurssturz der Aktie geführt, nachdem das Unternehmen einen Verlust von 3,33…
Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall…
Moderna cuts guidance on low EU sales, competitive vaccine environment in the U.S.…
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance…
Moderna Inc.’s stock tumbled 12% premarket Thursday, after the biotech cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter...…
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance…
Moderna reins in 2024 sales forecast, expects very low EU vaccine revenue…
Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for…
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Investors will likely focus on updates on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.…
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Shares of Moderna (MRNA) continue to soar thanks to the encouraging development of its non-COVID pipeline. The companys potential product…
The biotech is proving that its not a pandemic stock.…
Biotech investor Flagship Pioneering has raised $3.6 billion dollars for ventures in health, sustainability and AI. With $14 billion dollars…
Microsoft and Apple dropped plans to take board roles at OpenAI in a surprise decision that underscores growing regulatory scrutiny of Big Tech’s…
Incubator Flagship Pioneering plans to finance and launch array of companies using AI for pharmaceutical development…
Top-ranked stocks Chewy (CHWY), Wingstop (WING), Moderna (MRNA), Tenet Healthcare (THC) and Kinross Gold (KGC) are likely to beat on…
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
mRNA specialist CureVac, which struggled to compete with the likes of Pfizer, Moderna and BioNTech, said it will focus on…
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus,…
The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said…
Funding from U.S. biodefense agency Barda will support Moderna in developing an mRNA-based pandemic flu vaccine as fears grow the…
If approved, the RSV vaccine will be Modernas (MRNA) second approved product in the European Union.…
…
Christian Hollendieck, Spezialist Aktien der ICF BANK AG, fasst die vergangene Handelswoche zusammen. Der Deutsche Leitindex bewegt sich weiter in…
IRW-PRESS: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Marktzulassung von Modernas RSV-Impfstoff mRESVIA(R)CAMBRIDGE, MA…
IRW-PRESS: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Marktzulassung von…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Evercore ISI:
Cory Kasimov, Analyst von Evercore ISI, bestätigt sein Rating und Kursziel für die…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co:
Die Analysten von Jefferies & Co raten in einer aktuellen Aktienanalyse weiterhin…
Die Aktie von Moderna stand am Mittwoch massiv unter Druck. Mit einem Verlust von mehr als zehn Prozent war sie…
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 6% after US authorities recommended restrictions on doses of any respiratory syncytial virus (RSV) vaccine.…
After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV)…